AIWorldNewz.com

Eli Lilly Sees Positive Indian Response to Mounjaro

Source: Eli Lilly says India response to obesity drug Mounjaro is 'positive', will focus on meeting demand (2025-06-21)

Eli Lilly has reported a positive response from India regarding its obesity drug, Mounjaro, and plans to focus on the market through 2025. The company is optimistic about expanding its presence in India, aiming to leverage the growing demand for obesity treatments and diabetes management solutions. The pharmaceutical giant highlighted that India presents significant opportunities for Mounjaro, especially as awareness and acceptance of obesity-related health issues increase. Lilly intends to tailor its strategies to the Indian market, emphasizing local needs and regulatory pathways to accelerate the drug's availability and adoption.

More recent coverage